Reliability and reproducibility of dopamine D2 receptor binding measured with dual-bolus injections of [11C]raclopride

Trial Profile

Reliability and reproducibility of dopamine D2 receptor binding measured with dual-bolus injections of [11C]raclopride

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Dec 2014

At a glance

  • Drugs Raclopride (Primary)
  • Indications Psychotic disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 26 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 05 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top